(Q35620871)

9 August 2017

1 reference

title

Epidemiology of prostate cancer. (English)

1 reference

9 August 2017

1 reference

1 reference

E David Crawford

1

1 reference

PubMed ID

14706503

9 August 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

9 August 2017

1 reference

9 August 2017

62

1 reference

9 August 2017

3-12

1 reference

9 August 2017

6 Suppl 1

1 reference

Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Prostate cancer epidemiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

The ageing male: demographics and challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Epidemiology of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Family history and the risk of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Mendelian inheritance of familial prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Perspective: prostate cancer susceptibility genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

A prospective study of dietary fat and risk of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Dietary fat intake and risk of prostate cancer: A prospective study of 25,708 Norwegian men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

7 January 2021

Diet and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Hormones and prostate cancer: what's next?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Early growth, adult body size and prostate cancer risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Bone mass and the risk of prostate cancer: The Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Does amount or type of alcohol influence the risk of prostate cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Tomato products, lycopene, and prostate cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

A prospective study of tomato products, lycopene, and prostate cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Serum selenium and risk of prostate cancer in U.S. blacks and whites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Reduced risk of prostate cancer among patients with diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Diabetes mellitus and the risk of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

American Cancer Society guidelines for the early detection of cancer, 2003.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Prostate-specific antigen best practice policy--part I: early detection and diagnosis of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Screening for prostate cancer with prostate-specific antigen: beware the biases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

7 January 2021

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Trends in prostate cancer mortality among black men and white men in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Cause of death in men diagnosed with prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Improved prostate cancer-specific survival and other disease parameters: impact of prostate-specific antigen testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Epidemiology of radical prostatectomy for localized prostate cancer in the era of prostate-specific antigen: an overview of the Department of Defense Center for Prostate Disease Research national database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

Clinical evidence for and implications of the multistep development of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Prostate cancer incidence, mortality, and survival trends in the United States: 1981-2001.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.10.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UROLOGY.2003.10.013

1 reference

9 August 2017

1 reference

PubMed ID

14706503